Abstract

Enzymes serve as fundamental catalysts in biochemical reactions, orchestrating the complex metabolic pathways that sustain life. Among these processes, drug metabolism represents a critical pharmacokinetic phenomenon that directly influences therapeutic efficacy and safety. This paper examines the intricate relationship between enzyme kinetics and drug metabolism, emphasizing the pivotal role of biochemical principles in pharmaceutical sciences. The focus encompasses Michaelis-Menten kinetics as the foundational framework for understanding enzyme-substrate interactions, the cytochrome P450 enzyme system as the primary mediator of drug biotransformation, first-pass metabolism effects on bioavailability, and the complex mechanisms underlying drug-drug interactions. Clinical implications are explored through the lens of pharmacogenomics and personalized medicine, highlighting how genetic variations in metabolic enzymes contribute to inter-individual differences in drug response. The integration of computational modeling and experimental approaches provides insights into predictive drug metabolism studies. This comprehensive analysis aims to bridge the gap between fundamental biochemical enzyme kinetics and their practical applications in therapeutic drug design, ultimately contributing to the advancement of personalized medicine and improved patient outcomes through rational drug development strategies.